BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33318034)

  • 1. A Call to Action: Dismantling Racial Injustices in Preclinical Research and Clinical Care of Black Patients Living with Small Cell Lung Cancer.
    Thomas PL; Madubata CJ; Aldrich MC; Lee MM; Owonikoko TK; Minna JD; Rudin CM; Sage J; Lovly CM
    Cancer Discov; 2021 Feb; 11(2):240-244. PubMed ID: 33318034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Race, Socioeconomic Factors, and Treatment Characteristics With Overall Survival in Patients With Limited-Stage Small Cell Lung Cancer.
    Zhou K; Shi H; Chen R; Cochuyt JJ; Hodge DO; Manochakian R; Zhao Y; Ailawadhi S; Lou Y
    JAMA Netw Open; 2021 Jan; 4(1):e2032276. PubMed ID: 33433596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cell lung cancer: will recent progress lead to improved outcomes?
    Pietanza MC; Byers LA; Minna JD; Rudin CM
    Clin Cancer Res; 2015 May; 21(10):2244-55. PubMed ID: 25979931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Small-Cell Lung Cancer (SCLC) Translational Research.
    Drapkin BJ; Rudin CM
    Cold Spring Harb Perspect Med; 2021 Apr; 11(4):. PubMed ID: 32513672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
    Owonikoko TK; Zhang G; Kim HS; Stinson RM; Bechara R; Zhang C; Chen Z; Saba NF; Pakkala S; Pillai R; Deng X; Sun SY; Rossi MR; Sica GL; Ramalingam SS; Khuri FR
    J Transl Med; 2016 May; 14(1):111. PubMed ID: 27142472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel targeted strategies to overcome resistance in small-cell lung cancer: focus on PARP inhibitors and rovalpituzumab tesirine.
    Van Den Borg R; Leonetti A; Tiseo M; Giovannetti E; Peters GJ
    Expert Rev Anticancer Ther; 2019 Jun; 19(6):461-471. PubMed ID: 31148500
    [No Abstract]   [Full Text] [Related]  

  • 7. [Other thoracic cancers. Small-cell lung cancer: an update].
    Vermaelen K; van Meerbeeck JP
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S173-82. PubMed ID: 18971843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges.
    Leonetti A; Facchinetti F; Minari R; Cortellini A; Rolfo CD; Giovannetti E; Tiseo M
    Cell Oncol (Dordr); 2019 Jun; 42(3):261-273. PubMed ID: 30968324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lurbinectedin for the treatment of small cell lung cancer.
    Li L; Zou C; Dong S; Wu ZX; Ashby CR; Chen ZS; Qiu C
    Drugs Today (Barc); 2021 Jun; 57(6):377-385. PubMed ID: 34151904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New targeted therapies and small-cell lung cancer.
    Rossi A; Maione P; Palazzolo G; Sacco PC; Ferrara ML; Falanga M; Gridelli C
    Clin Lung Cancer; 2008 Sep; 9(5):271-9. PubMed ID: 18824449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
    Ragavan M; Das M
    Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model].
    Zhu Y; Huang W; Wu Y; Jia L; Li Y; Chen R; Guo L; Chen Q
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):6-14. PubMed ID: 30674387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganitumab for the treatment of small-cell lung cancer.
    Martínez P; Sales Fidalgo PA; Felip E
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1423-32. PubMed ID: 25189625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapies for small cell lung cancer: Where do we stand?
    Arcaro A
    Crit Rev Oncol Hematol; 2015 Aug; 95(2):154-64. PubMed ID: 25800975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Therapy of Small Cell Lung Cancer.
    Schneider BJ; Kalemkerian GP
    Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.
    Némati F; Daniel C; Arvelo F; Legrier ME; Froget B; Livartowski A; Assayag F; Bourgeois Y; Poupon MF; Decaudin D
    Anticancer Drugs; 2010 Jan; 21(1):25-32. PubMed ID: 19823076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Therapeutic Options for Small Cell Lung Cancer.
    Canova S; Trevisan B; Abbate MI; Colonese F; Sala L; Baggi A; Bianchi SP; D'Agostino A; Cortinovis DL
    Curr Oncol Rep; 2023 Nov; 25(11):1277-1294. PubMed ID: 37870696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer.
    Gaponova AV; Nikonova AS; Deneka A; Kopp MC; Kudinov AE; Skobeleva N; Khazak V; Ogawa LS; Cai KQ; Duncan KE; Duncan JS; Egleston BL; Proia DA; Boumber Y; Golemis EA
    Clin Cancer Res; 2016 Oct; 22(20):5120-5129. PubMed ID: 27267850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Smoking With Patient Characteristics and Outcomes in Small Cell Lung Carcinoma, 2011-2018.
    Tseng JS; Chiang CJ; Chen KC; Zheng ZR; Yang TY; Lee WC; Hsu KH; Huang YH; Liu TW; Hsia JY; Chang GC
    JAMA Netw Open; 2022 Mar; 5(3):e224830. PubMed ID: 35353165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate treatment of small cell lung cancer: Current progress, new challenges and expectations.
    Zhang C; Wang H
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188798. PubMed ID: 36096336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.